{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:20:18Z","timestamp":1788952818261,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100016952","name":"Cogent Biosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016952","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11136-026-04291-z","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:44:24Z","timestamp":1781873064000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Psychometric evaluation of the Mastocytosis Symptom Severity Daily Diary (MS2D2) in adults with nonadvanced systemic mastocytosis (NonAdvSM)"],"prefix":"10.1007","volume":"35","author":[{"given":"James C.","family":"Marcus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Easton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Lim-Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Siebenhaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Gwaltney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"issue":"10","key":"4291_CR1","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3324\/haematol.2016.146563","volume":"101","author":"C Ustun","year":"2016","unstructured":"Ustun, C., Arock, M., Kluin-Nelemans, H. C., Reiter, A., Sperr, W. R., George, T., & Valent, P. (2016). Advanced systemic mastocytosis: From molecular and genetic progress to clinical practice. Haematologica, 101(10), 1133\u20131143. https:\/\/doi.org\/10.3324\/haematol.2016.146563","journal-title":"Haematologica"},{"issue":"12","key":"4291_CR2","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.6004\/jnccn.2018.0088","volume":"16","author":"J Gotlib","year":"2018","unstructured":"Gotlib, J., Gerds, A. T., Bose, P., Castells, M. C., Deininger, M. W., Gojo, I., & Sundar, H. (2018). Systemic mastocytosis, version 2.2019, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 16(12), 1500\u20131537. https:\/\/doi.org\/10.6004\/jnccn.2018.0088","journal-title":"Journal of the National Comprehensive Cancer Network"},{"issue":"3","key":"4291_CR3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ajh.25371","volume":"94","author":"A Pardanani","year":"2019","unstructured":"Pardanani, A. (2019). Systemic mastocytosis in adults: 2019 Update on diagnosis, risk stratification and management. American Journal of Hematology, 94(3), 363\u2013377. https:\/\/doi.org\/10.1002\/ajh.25371","journal-title":"American Journal of Hematology"},{"issue":"4","key":"4291_CR4","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/ajh.26118","volume":"96","author":"A Pardanani","year":"2021","unstructured":"Pardanani, A. (2021). Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management. American Journal of Hematology, 96(4), 508\u2013525. https:\/\/doi.org\/10.1002\/ajh.26118","journal-title":"American Journal of Hematology"},{"issue":"11","key":"4291_CR5","doi-asserted-by":"publisher","first-page":"e646","DOI":"10.1097\/HS9.0000000000000646","volume":"5","author":"P Valent","year":"2021","unstructured":"Valent, P., Akin, C., Hartmann, K., Alvarez-Twose, I., Brockow, K., Hermine, O., & Metcalfe, D. D. (2021). Updated diagnostic criteria and classification of mast cell disorders: A consensus proposal. HemaSphere, 5(11), e646. https:\/\/doi.org\/10.1097\/HS9.0000000000000646","journal-title":"HemaSphere"},{"issue":"16","key":"4291_CR6","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.3390\/cancers14163942","volume":"14","author":"J Ungerstedt","year":"2022","unstructured":"Ungerstedt, J., Ljung, C., Klimkowska, M., & G\u00fclen, T. (2022). Clinical outcomes of adults with systemic mastocytosis: A 15-year multidisciplinary experience. Cancers, 14(16), 3942. https:\/\/doi.org\/10.3390\/cancers14163942","journal-title":"Cancers"},{"issue":"4","key":"4291_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/bjh.12916","volume":"166","author":"SS Cohen","year":"2014","unstructured":"Cohen, S. S., Skovbo, S., Vestergaard, H., Kristensen, T., M\u00f8ller, M., Bindslev-Jensen, C., & Broesby-Olsen, S. (2014). Epidemiology of systemic mastocytosis in Denmark. British Journal of Haematology, 166(4), 521\u2013528. https:\/\/doi.org\/10.1111\/bjh.12916","journal-title":"British Journal of Haematology"},{"issue":"11","key":"4291_CR8","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/ajh.24490","volume":"91","author":"S Broesby-Olsen","year":"2016","unstructured":"Broesby-Olsen, S., Farkas, D. K., Vestergaard, H., Hermann, A. P., M\u00f8ller, M. B., Mortz, C. G., & Frederiksen, H. (2016). Risk of solid cancer, cardiovascular disease, anaphylaxis, osteoporosis and fractures in patients with systemic mastocytosis: A nationwide population-based study. American Journal of Hematology, 91(11), 1069\u20131075. https:\/\/doi.org\/10.1002\/ajh.24490","journal-title":"American Journal of Hematology"},{"issue":"4","key":"4291_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1159\/000329218","volume":"157","author":"F Wimazal","year":"2012","unstructured":"Wimazal, F., Geissler, P., Shnawa, P., Sperr, W. R., & Valent, P. (2012). Severe life-threatening or disabling anaphylaxis in patients with systemic mastocytosis: A single-center experience. International Archives of Allergy and Immunology, 157(4), 399\u2013405. https:\/\/doi.org\/10.1159\/000329218","journal-title":"International Archives of Allergy and Immunology"},{"issue":"3","key":"4291_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.iac.2018.04.006","volume":"38","author":"SV Jennings","year":"2018","unstructured":"Jennings, S. V., Slee, V. M., Zack, R. M., Verstovsek, S., George, T. I., Shi, H., & Castells, M. C. (2018). Patient perceptions in mast cell disorders. Immunology and Allergy Clinics of North America, 38(3), 505\u2013525. https:\/\/doi.org\/10.1016\/j.iac.2018.04.006","journal-title":"Immunology and Allergy Clinics of North America"},{"issue":"11","key":"4291_CR11","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1111\/all.12920","volume":"71","author":"B van Anrooij","year":"2016","unstructured":"van Anrooij, B., Kluin-Nelemans, J. C., Safy, M., Flokstra-de Blok, B. M. J., & Oude Elberink, J. N. G. (2016). Patient-reported disease-specific quality-of-life and symptom severity in systemic mastocytosis. Allergy, 71(11), 1585\u20131593. https:\/\/doi.org\/10.1111\/all.12920","journal-title":"Allergy"},{"key":"4291_CR12","doi-asserted-by":"publisher","first-page":"S666","DOI":"10.1016\/S2152-2650(25)02122-6","volume":"25","author":"F Siebenhaar","year":"2025","unstructured":"Siebenhaar, F., Sparling, N., Paty, J., Akin, C., Nicoloro-SantaBarbara, J., Lyons, C. N., & Ruzich, E. (2025). MPN-573: Development of the Mastocytosis Symptom Severity Daily Diary (MS2D2) for Non-Advanced Systemic Mastocytosis patients and establishing content validity. Clinical Lymphoma, Myeloma and Leukemia, 25, S666. https:\/\/doi.org\/10.1016\/S2152-2650(25)02122-6","journal-title":"Clinical Lymphoma, Myeloma and Leukemia"},{"issue":"7","key":"4291_CR13","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1111\/all.13425","volume":"73","author":"F Siebenhaar","year":"2018","unstructured":"Siebenhaar, F., Sander, B., Ho, L. H. T., Ellrich, A., Maurer, M., & Weller, K. (2018). Development and validation of the Mastocytosis activity score. Allergy, 73(7), 1489\u20131496. https:\/\/doi.org\/10.1111\/all.13425","journal-title":"Allergy"},{"issue":"6","key":"4291_CR14","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/all.12842","volume":"71","author":"F Siebenhaar","year":"2016","unstructured":"Siebenhaar, F., von Tschirnhaus, E., Hartmann, K., Rabenhorst, A., Staubach, P., Peveling-Oberhag, A., & Weller, K. (2016). Development and validation of the mastocytosis quality of life questionnaire: MC-QoL. Allergy, 71(6), 869\u2013877. https:\/\/doi.org\/10.1111\/all.12842","journal-title":"Allergy"},{"issue":"10","key":"4291_CR15","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., & Badia, X. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 20(10), 1727\u20131736. https:\/\/doi.org\/10.1007\/s11136-011-9903-x","journal-title":"Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation"},{"key":"4291_CR16","doi-asserted-by":"crossref","unstructured":"Cappelleri, J. (2014). Patient-reported outcomes: Measurement, implementation and interpretation.","DOI":"10.1201\/b16139"},{"issue":"3","key":"4291_CR17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1037\/a0029315","volume":"17","author":"M Rhemtulla","year":"2012","unstructured":"Rhemtulla, M., Brosseau-Liard, P. \u00c9., & Savalei, V. (2012). When can categorical variables be treated as continuous? A comparison of robust continuous and categorical SEM estimation methods under suboptimal conditions. Psychological Methods, 17(3), 354\u2013373. https:\/\/doi.org\/10.1037\/a0029315","journal-title":"Psychological Methods"},{"key":"4291_CR18","volume-title":"Psychometric theory","author":"JC Nunnally","year":"1994","unstructured":"Nunnally, J. C., & Bernstein, I. H. (1994). Psychometric theory. McGraw-Hill Companies, Incorporated."},{"issue":"2","key":"4291_CR19","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1037\/0033-2909.86.2.420","volume":"86","author":"PE Shrout","year":"1979","unstructured":"Shrout, P. E., & Fleiss, J. L. (1979). Intraclass correlations: Uses in assessing rater reliability. Psychological Bulletin, 86(2), 420\u2013428. https:\/\/doi.org\/10.1037\/0033-2909.86.2.420","journal-title":"Psychological Bulletin"},{"issue":"1","key":"4291_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1037\/1082-989X.1.1.30","volume":"1","author":"KO McGraw","year":"1996","unstructured":"McGraw, K. O., & Wong, S. P. (1996). Forming inferences about some intraclass correlation coefficients. Psychological Methods, 1(1), 30\u201346. https:\/\/doi.org\/10.1037\/1082-989X.1.1.30","journal-title":"Psychological Methods"},{"issue":"10","key":"4291_CR21","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.4065\/82.10.1244","volume":"82","author":"EA Hahn","year":"2007","unstructured":"Hahn, E. A., Cella, D., Chassany, O., Fairclough, D. L., Wong, G. Y., & Hays, R. D. (2007). Precision of health-related quality-of-life data compared with other clinical measures. Mayo Clinic Proceedings, 82(10), 1244\u20131254. https:\/\/doi.org\/10.4065\/82.10.1244","journal-title":"Mayo Clinic Proceedings"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04291-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-026-04291-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04291-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:05:11Z","timestamp":1788951911000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-026-04291-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4291"],"URL":"https:\/\/doi.org\/10.1007\/s11136-026-04291-z","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was funded by Cogent Biosciences. RE and JZ are employees and stockholders of Cogent Biosciences. MLW is a contractor for Cogent Bioscience. FS has received honoraria and consulting fees from Blueprint Medicines, Noucor, Sanofi, and Novartis. CA has received research funding and consulting fees from Cogent Biosciences, Blueprint Medicines, and Telios, and has served as a consultant for Novartis.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in line with the principles of Helsinki and Council for International Organizations of Medical Sciences International Ethical guidelines and the International Conference on Harmonization guidelines on Good Clinical Practice. All informed consent forms and protocols were approved by appropriate ethical review boards before initiation of the study (IRB #20214788). All participants provided written informed consent before any study procedures were performed and before study drug administration.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No additional consent was required for the analyses described.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"207"}}